CinnoRA (Adalimumab) 40mg/0.8ml Injection In Pakistan

CinnoRA (Adalimumab) 40 mg/0.8 ml Injection, a biologic medication manufactured by CinnaGen. CinnoRA (Adalimumab) 40mg/0.8mL Injection is a biologic medicine containing adalimumab, a recombinant human monoclonal antibody. It belongs to a class of medicines known as Tumor Necrosis Factor (TNF) inhibitors.

Adalimumab works by blocking TNF-alpha, a protein involved in inflammation. It helps reduce inflammation, swelling, pain, and other symptoms associated with certain autoimmune and inflammatory diseases.

CinnoRA may be prescribed by specialist doctors for conditions such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis, plaque psoriasis, and certain inflammatory bowel diseases.

Product Information

Uses of CinnoRA (Adalimumab) Injection

CinnoRA 40mg/0.8mL may be prescribed for the treatment of several inflammatory and autoimmune conditions, including:

1. Rheumatoid Arthritis

Helps reduce joint inflammation, pain, swelling, and stiffness in patients with rheumatoid arthritis.

2. Ankylosing Spondylitis

Helps control inflammation affecting the spine and other joints.

3. Psoriatic Arthritis

Helps manage joint inflammation and symptoms associated with psoriatic arthritis.

4. Plaque Psoriasis

May help reduce skin inflammation, redness, scaling, and thick plaques.

5. Crohn's Disease

Used in selected patients to help control inflammation in the digestive tract.

6. Ulcerative Colitis

May be prescribed to manage moderate to severe ulcerative colitis in eligible patients.

7. Hidradenitis Suppurativa

May help reduce inflammatory skin lesions and painful abscesses in eligible patients.

How Does CinnoRA Work?

CinnoRA contains adalimumab, which selectively binds to Tumor Necrosis Factor-alpha (TNF-alpha).

TNF-alpha is an inflammatory protein that contributes to inflammation in several autoimmune conditions.

By blocking TNF-alpha, adalimumab helps:

• Reduce inflammatory activity.

• Control swelling and joint pain.

• Improve symptoms of autoimmune diseases.

• Reduce skin inflammation in certain conditions.

• Improve disease management and quality of life.

Benefits of CinnoRA 40mg/0.8mL Injection

• Helps control TNF-alpha-related inflammation.

• Supports the management of rheumatoid arthritis.

• Helps reduce symptoms of ankylosing spondylitis.

• May improve symptoms of psoriatic arthritis.

• Helps manage certain inflammatory skin conditions.

• Provides targeted biologic therapy for eligible patients.

Dosage and Administration

CinnoRA 40mg/0.8mL is administered by subcutaneous injection.

The recommended dosage depends on the patient's condition, age, medical history, and response to treatment.

Important administration guidelines:

• Use only according to the prescribing specialist's instructions.

• Follow the recommended injection schedule.

• Do not change or discontinue treatment without medical advice.

• A healthcare professional should demonstrate the correct injection technique.

• Do not use the injection if the packaging is damaged or the medicine appears abnormal.

Possible Side Effects

Some patients may experience side effects while using Adalimumab.

Common side effects include:

• Injection-site redness or swelling.

• Headache.

• Nausea.

• Skin rash.

• Upper respiratory tract infections.

• Sinus infections.

• Mild allergic reactions.

Serious Side Effects

Seek immediate medical attention if you experience:

• Serious infections.

• Tuberculosis symptoms.

• Severe allergic reactions.

• Unusual bruising or bleeding.

• Neurological symptoms.

• Symptoms of liver problems.

Warnings and Precautions

Before starting CinnoRA treatment, inform your doctor if you:

• Have an active infection.

• Have a history of tuberculosis.

• Have hepatitis B or other chronic infections.

• Have a history of cancer.

• Have heart failure or neurological disorders.

• Are pregnant, planning pregnancy, or breastfeeding.

Important: Patients should be evaluated for tuberculosis and other relevant infections before starting treatment. Live vaccines should generally be avoided during adalimumab therapy.

Storage Instructions

• Store refrigerated at 2°C to 8°C.

• Do not freeze.

• Keep the injection in its original carton to protect it from light.

• Do not shake the injection.

• Follow the manufacturer's instructions regarding room-temperature storage.

• Keep out of reach of children.

CinnoRA (Adalimumab) 40mg/0.8mL Injection Price in Pakistan

The price of CinnoRA 40mg/0.8mL Injection in Pakistan /350000

For the latest price and stock information, contact an authorized pharmaceutical supplier at Onlinetrade.pk

Available in Major Cities

Lahore, Karachi, Islamabad, Rawalpindi, Faisalabad, Multan, Bahawalpur, Peshawar, Gujranwala, Hyderabad, Sialkot, Sukkur, Larkana and other major cities of Pakistan.

Frequently Asked Questions (FAQs)

1. What is CinnoRA 40mg/0.8mL Injection used for?

CinnoRA contains adalimumab and is used to treat certain autoimmune and inflammatory diseases, including rheumatoid arthritis, ankylosing spondylitis, and plaque psoriasis.

2. What is the active ingredient in CinnoRA?

The active ingredient is adalimumab, a TNF-alpha inhibitor.

3. How is CinnoRA administered?

It is administered as a subcutaneous injection according to the prescribed treatment schedule.

4. Does CinnoRA require refrigeration?

Yes. It should generally be stored in a refrigerator at 2°C to 8°C and must not be frozen. Follow the manufacturer's storage instructions.

5. Can CinnoRA be used for rheumatoid arthritis?

Yes. Adalimumab is an established treatment option for eligible patients with rheumatoid arthritis.